A carregar...
Aztreonam Lysine Inhalation Solution in Cystic Fibrosis
Patients with cystic fibrosis (CF) develop pulmonary disease secondary to airway infection and dysregulated inflammation. Therapeutic innovations such as nebulized antimicrobial therapy targeting specific pathogens have resulted in improvements in quality of life and life expectancy. Aztreonam lysin...
Na minha lista:
| Publicado no: | Clin Med Insights Circ Respir Pulm Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463232/ https://ncbi.nlm.nih.gov/pubmed/31019373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179548419842822 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|